R.S. Suri

Type de document

Co-auteur

C. Tremblay

A. Tauzin

O. Tastet

A.M. Sreng Flores

G. Sannier

N. Rios

A. Prat

J. Niessl

A. Nicolas

M. Nayrac

C. Morrisseau

H. Medjahed

L. Marchitto

M. Laporte

C. Lamarche

D.E. Kaufmann

G. Goyette

R. Goupil

S.Y. Gong

L. Gokool

A. Finzi

M. Dubé

S. Ding

G.G. Delgado

R. Cloutier

D. Chatterjee

N. Brassard

M. Boutin

C. Bourassa

M. Benlarbi

J. Bélair

P. Arlotto

Date

Source

Serveur académique Lausannois (1)

Mot-clé

temps (durée) (1) protéine (1) anticorps (1) immunité (1) dose (1) Defects (1) Control (1) Tumor necrosis factor (1) Vaccines (1) Vaccination (1) Ci (Chinese poetry) (1) Time (1) Persons (1) Patients (1) Messenger RNA (1) Human beings (1) Immunity (1) Hemodialysis--Patients (1) Hemodialysis (1) Defects (1) Cells (1) Cell death (1) SARS (Disease) (1) Vaccination (1) Patients (1)

Documents écrit par R.S. Suri (1) | parle de R.S. Suri (0)

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile.

G. Sannier et al. (21 mars 2023)